Press Release

Oncology Information Systems Market to Drive with the Flooding Cancer Patient Pool & Substantial Healthcare Funding

The Global Oncology Information Systems Market size is valued at around USD 4.2 Billion in 2023 and is projected to grow at a CAGR of around 6.2% during the forecast period 2024-30, cites MarkNtel Advisors in their recent research report. The market is driven by the rapidly increasing cancer cases globally, demonstrating an alarming need to find more reliable & effective diagnoses, treatments, and patients care. In addition to the advent of new technologies like artificial intelligence (AI) in various industries, including the healthcare sector, the utilization of oncology information systems is widening to reap the benefits & bring progress & efficiency to the industry.

Besides, since oncology information systems facilitate treatment along with the more comprehensive coverage of every dimension, its popularity & demand for efficient treatment for cancer patients is escalating too. As a result, such factors are making these systems indispensable for management & generating lucrative opportunities for the leading companies to widen their service offering & stay afloat in the competition, further states the research report, “Global Oncology Information Systems Market Analysis, 2024.”

Software to Take Over the Oncology Information System Market with the Most Demand

Based on the offering, the market is bifurcated into Software (Patient Information Systems Software & Treatment Planning Systems Software) & Professional Services. Among them, Software is anticipated to dominate the Global Oncology Information System Market with the largest share during the forecast period. It owes principally to the capabilities of these software solutions to streamline cancer patients' information & schedule appropriate treatment along with other transactional details for billing & non-billing purposes.

Since software for oncology information systems provides IT solutions in healthcare settings by replacing the manual database with a web-based one, these solutions also minimize errors & swiftly gain momentum, helping healthcare professionals to enhance the performing treatments using proper analysis & research.

Massive Investments in the Healthcare Sector in North America to Drive the Market Through 2030

Geographically, North America is anticipated to prevail in its dominance from the previous years to the forecast years in the Global Oncology Information Systems Market during the forecast period. It owes principally to the high prevalence of cancer across countries like the US & Canada across the region, entwined with the massive investments by the governments in developing & procuring technologically advanced solutions for better cancer diagnosis, treatment, and care. It, in turn, is augmenting the demand for oncology information systems & contributing to the swift expansion of the market across North America during the forecast period.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Accuray Inc., BrainLab, Cerner Corp., DOSIsoft S.A., Elekta AB, Flatiron, McKesson Corporation, MIM Software, Philips Healthcare, Prowess, Inc., RaySearch Laboratories, Siemens Medical Solutions, Inc., Varian Medical Systems, ViewRay Inc., and others are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various region?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?